Rosemont has over 50 years of expertise in the development, manufacture and distribution of oral liquid medicines for patients unable to swallow solid medications. At our state-of-the-art manufacturing site in the UK, we produce over 4 million bottles of liquid medicine every year. Our focus on research and development is the key to growth in our portfolio and we continuously invest in our facilities to ensure we have the latest technologies to enhance our capabilities and capacity. For more information about Rosemont Pharmaceuticals, please view our corporate brochure.
At Rosemont, we believe that collaboration with other organisations is an essential component in our success.
Partnering with Rosemont
As a company, we are forward-looking and continuously open to new ideas and opportunities. Rosemont is a trusted name in liquid medicines and we already export our products to over 25 different countries. Our committed mission is to build on that momentum, expanding our distribution, wholesale and manufacturing partnerships into new countries and regions across the world, benefiting patients with swallowing difficulties.
Partnering with Rosemont gives you access to our unique expertise in liquid medicines, a continuously growing portfolio of innovative medicines and the latest technology in both R&D and manufacturing. We are keen to hear from you if:
- You are interested in becoming a distributor for the Rosemont liquid medicine portfolio
- You are a manufacturer looking for a partner with expertise and a proven track record in commercialising product in the UK
- You require a specialist contract manufacturer of liquid medicines
Alternatively, if you are in Europe, Russia, North or South America, you can schedule a meeting with our International Sales Manager Rupert Sargeant.
Rosemont Pharmaceuticals manufacture and supply over 130 oral liquid medicines covering most therapeutic categories. For more information about our liquid medicines, view our product pages or download the Rosemont app.
When developing products, we include only the minimal necessary excipients, to ensure suitability for patients with a variety of religious and dietary requirements. We aim to produce medicines which are suitable for diabetics and vegetarians. Other excipients such as glucose, lactose, sorbitol, fructose, gluten, aspartame, tartrazine, arachis oil and ethanol are avoided wherever possible. Low sodium levels are also a target. All our products comply with EU safe excipient level guidelines, reassuring our patients and healthcare professionals of their quality.
Rosemont are committed to the pursuit of excellence in everything that we do and therefore strive to uphold the highest quality standards. We adhere to Good Manufacturing Practice (GMP) and International Conference on Harmonisation (ICH) Q10 quality control guideline. Our manufacturing facilities are also regularly inspected and approved by both the UK and US pharmaceutical regulatory agencies. Additional approvals come from the many healthcare institutions, customers & companies purchasing Rosemont liquids worldwide.